Myocardial Bridging in Obstructive Hypertrophic Cardiomyopathy

CompletedOBSERVATIONAL
Enrollment

968

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Myocardial BridgingObstructive Hypertrophic CardiomyopathyAtrial Fibrillation (AF)
Interventions
PROCEDURE

Coronary artery bypass grafting or unroofing

Patients had an MB with \>75% compression degree would receive coronary artery bypass grafting, and those who underwent unroofing may had a depth of MB \< 5mm (whether deal with these MB with a depth \<5mm depends on the surgeon and the period time of patients received a surgery).

Trial Locations (1)

475

Fuwai Hospital, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

NCT06598995 - Myocardial Bridging in Obstructive Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter